Aizawa Yuka, Haga Kenta, Yoshiba Nagako, Yortchan Witsanu, Takada Sho, Tanaka Rintaro, Naito Eriko, Abé Tatsuya, Maruyama Satoshi, Yamazaki Manabu, Tanuma Jun-Ichi, Igawa Kazuyo, Tomihara Kei, Togo Shinsaku, Izumi Kenji
Division of Biomimetics, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.
Division of Oral and Maxillofacial Surgery, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.
Biomedicines. 2024 Oct 17;12(10):2373. doi: 10.3390/biomedicines12102373.
Cancer organoids have emerged as a valuable tool of three-dimensional (3D) cell cultures to investigate tumor heterogeneity and predict tumor behavior and treatment response. We developed a 3D organotypic culture model of oral squamous cell carcinoma (OSCC) to recapitulate the tumor-stromal interface by co-culturing four cell types, including patient-derived cancer-associated fibroblasts (PD-CAFs). : A stainless-steel ring was used twice to create the horizontal positioning of the cancer stroma (adjoining normal oral mucosa connective tissue) and the OSCC layer (surrounding normal oral mucosa epithelial layer). Combined with a structured bi-layered model of the epithelial component and the underlying stroma, this protocol enabled us to construct four distinct portions mimicking the oral cancer tissue arising in the oral mucosa. : In this model, α-smooth muscle actin-positive PD-CAFs were localized in close proximity to the OSCC layer, suggesting a crosstalk between them. Furthermore, a linear laminin-γ2 expression was lacking at the interface between the OSCC layer and the underlying stromal layer, indicating the loss of the basement membrane-like structure. : Since the specific 3D architecture and polarity mimicking oral cancer in vivo provides a more accurate milieu of the tumor microenvironment (TME), it could be crucial in elucidating oral cancer TME.
Front Cell Dev Biol. 2023-9-7
Cell Mol Gastroenterol Hepatol. 2021
Acta Biochim Biophys Sin (Shanghai). 2022-9-25
Eur J Nucl Med Mol Imaging. 2025-8-7
Cancers (Basel). 2025-3-25
Cell Death Discov. 2024-6-26
Biomicrofluidics. 2024-3-6
BME Front. 2023-6-16
Int J Oral Sci. 2023-9-22
Cancers (Basel). 2023-8-25
BioTech (Basel). 2023-5-11